• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致病性 BRCA1 变异破坏 PLK1 对有丝分裂纺锤体取向的调控。

Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation.

机构信息

Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, British Columbia, Canada.

出版信息

Nat Commun. 2022 Apr 22;13(1):2200. doi: 10.1038/s41467-022-29885-2.

DOI:10.1038/s41467-022-29885-2
PMID:35459234
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9033786/
Abstract

Preneoplastic mammary tissues from human female BRCA1 mutation carriers, or Brca1-mutant mice, display unexplained abnormalities in luminal differentiation. We now study the division characteristics of human mammary cells purified from female BRCA1 mutation carriers or non-carrier donors. We show primary BRCA1 mutant/+ cells exhibit defective BRCA1 localization, high radiosensitivity and an accelerated entry into cell division, but fail to orient their cell division axis. We also analyse 15 genetically-edited BRCA1 mutant/+ human mammary cell-lines and find that cells carrying pathogenic BRCA1 mutations acquire an analogous defect in their division axis accompanied by deficient expression of features of mature luminal cells. Importantly, these alterations are independent of accumulated DNA damage, and specifically dependent on elevated PLK1 activity induced by reduced BRCA1 function. This essential PLK1-mediated role of BRCA1 in controlling the cell division axis provides insight into the phenotypes expressed during BRCA1 tumorigenesis.

摘要

来自携带人源 BRCA1 基因突变的女性或 Brca1 突变小鼠的癌前乳腺组织表现出管腔分化中无法解释的异常。我们现在研究从携带 BRCA1 基因突变的女性或非携带者供体中纯化的人乳腺细胞的分裂特征。我们发现原发性 BRCA1 突变体/+细胞表现出 BRCA1 定位缺陷、高放射敏感性和加速进入细胞分裂,但无法确定其细胞分裂轴。我们还分析了 15 种经过基因编辑的 BRCA1 突变体/+人乳腺细胞系,发现携带致病性 BRCA1 突变的细胞在其分裂轴上获得类似的缺陷,同时成熟管腔细胞的特征表达也不足。重要的是,这些改变不依赖于累积的 DNA 损伤,而是特异性地依赖于由 BRCA1 功能降低引起的 PLK1 活性升高。BRCA1 在控制细胞分裂轴中的这个必需的 PLK1 介导作用,为 BRCA1 肿瘤发生过程中表达的表型提供了深入的了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/58a4cab83612/41467_2022_29885_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/f275d7ddd662/41467_2022_29885_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/a94ace2af647/41467_2022_29885_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/28be00f847e2/41467_2022_29885_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/be8c124c0f22/41467_2022_29885_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/54dbc293c5f5/41467_2022_29885_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/285149d622e7/41467_2022_29885_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/58a4cab83612/41467_2022_29885_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/f275d7ddd662/41467_2022_29885_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/a94ace2af647/41467_2022_29885_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/28be00f847e2/41467_2022_29885_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/be8c124c0f22/41467_2022_29885_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/54dbc293c5f5/41467_2022_29885_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/285149d622e7/41467_2022_29885_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3620/9033786/58a4cab83612/41467_2022_29885_Fig7_HTML.jpg

相似文献

1
Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation.致病性 BRCA1 变异破坏 PLK1 对有丝分裂纺锤体取向的调控。
Nat Commun. 2022 Apr 22;13(1):2200. doi: 10.1038/s41467-022-29885-2.
2
Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1.在BRCA1、p53缺陷的乳腺肿瘤细胞中,多西他赛的反应受亨廷顿蛋白和BAP1影响。
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2402849121. doi: 10.1073/pnas.2402849121. Epub 2024 Dec 20.
3
Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery.PLK1活性的结构调控:对细胞周期功能和药物发现的影响。
Cancer Gene Ther. 2025 May 16. doi: 10.1038/s41417-025-00907-7.
4
Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.Plk1 的过表达促进人食管鳞癌细胞的恶性进展。
J Cancer Res Clin Oncol. 2010 Jan;136(1):9-16. doi: 10.1007/s00432-009-0630-4.
5
Overexpression of oncogenic polo-like kinase 1 disrupts the invasiveness, cell cycle, and apoptosis in synovial sarcoma.致癌性polo样激酶1的过表达会破坏滑膜肉瘤的侵袭性、细胞周期和细胞凋亡。
J Transl Med. 2025 Jun 20;23(1):691. doi: 10.1186/s12967-025-06740-8.
6
PLK-1 suppresses centrosome maturation and microtubule polymerization to ensure faithful oocyte meiosis.PLK-1抑制中心体成熟和微管聚合以确保卵母细胞减数分裂正常进行。
J Cell Biol. 2025 Sep 1;224(9). doi: 10.1083/jcb.202503080. Epub 2025 Jun 27.
7
BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress.BRCA1 下调 Polo 样激酶 1 的激酶活性以响应复制应激。
Cell Cycle. 2013 Jul 15;12(14):2255-65. doi: 10.4161/cc.25349.
8
PLK1-mediated phosphorylation of WDR62/MCPH2 ensures proper mitotic spindle orientation.PLK1介导的WDR62/MCPH2磷酸化确保有丝分裂纺锤体正确定向。
Hum Mol Genet. 2017 Nov 15;26(22):4429-4440. doi: 10.1093/hmg/ddx330.
9
MLN0905 effectively kills gemcitabine-resistant pancreatic cancer cells by targeting PLK1.MLN0905通过靶向PLK1有效杀死吉西他滨耐药的胰腺癌细胞。
Eur J Med Res. 2025 Jul 3;30(1):567. doi: 10.1186/s40001-025-02825-8.
10
Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.Polo-like 激酶在非小细胞肺癌中的表达分析及其预后价值。
J Cancer Res Clin Oncol. 2020 Oct;146(10):2447-2460. doi: 10.1007/s00432-020-03288-6. Epub 2020 Jul 5.

引用本文的文献

1
Establishment of salivary tissue-organoid biorepository: characterizing salivary gland stem/progenitor cells and novel differentiation marker PSMA/FOLH1.唾液组织类器官生物样本库的建立:唾液腺干/祖细胞及新型分化标志物PSMA/FOLH1的表征
NPJ Regen Med. 2025 May 21;10(1):23. doi: 10.1038/s41536-025-00410-5.
2
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant.具有BRCA1致病变异的女性的生育次数、母乳喂养与早发性乳腺癌风险
Br J Cancer. 2025 May 2. doi: 10.1038/s41416-025-03029-x.
3
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.

本文引用的文献

1
A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast.人类乳腺正常、癌前病变和肿瘤发生状态的单细胞 RNA 表达图谱。
EMBO J. 2021 Jun 1;40(11):e107333. doi: 10.15252/embj.2020107333. Epub 2021 May 5.
2
Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in Mutation Carriers.单细胞 RNA 测序揭示了突变携带者乳腺癌的细胞起源和演化。
Cancer Res. 2021 May 15;81(10):2600-2611. doi: 10.1158/0008-5472.CAN-20-2123. Epub 2021 Mar 16.
3
PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways.
BRCA1的三十年:机制洞察及其对突变携带者的影响
Cancer Discov. 2025 Mar 3;15(3):461-480. doi: 10.1158/2159-8290.CD-24-1326.
4
Novel BRCA1-PLK1-CIP2A axis orchestrates homologous recombination-mediated DNA repair to maintain chromosome integrity during oocyte meiosis.新型BRCA1-PLK1-CIP2A轴协调同源重组介导的DNA修复,以在卵母细胞减数分裂期间维持染色体完整性。
Nucleic Acids Res. 2025 Jan 11;53(2). doi: 10.1093/nar/gkae1207.
5
CoGTEx: Unscaled system-level coexpression estimation from GTEx data forecast novel functional gene partners.CoGTEx:从 GTEx 数据预测新的功能基因伙伴的无标度系统水平共表达估计。
PLoS One. 2024 Oct 4;19(10):e0309961. doi: 10.1371/journal.pone.0309961. eCollection 2024.
6
Functional Characterization of the Human BRCA1 ∆11 Splicing Isoforms in Yeast.在酵母中对人类 BRCA1 ∆11 剪接异构体的功能进行鉴定。
Int J Mol Sci. 2024 Jul 9;25(14):7511. doi: 10.3390/ijms25147511.
7
The Mayo Clinic Salivary Tissue-Organoid Biobanking: A Resource for Salivary Regeneration Research.梅奥诊所唾液组织类器官生物样本库:唾液再生研究的资源
bioRxiv. 2024 Feb 27:2024.02.23.581761. doi: 10.1101/2024.02.23.581761.
8
Oncogenic BRCA1,2 Mutations in the Human Lineage-A By-Product of Sexual Selection?人类谱系中致癌性BRCA1、2基因突变——性选择的副产品?
Biomedicines. 2023 Dec 21;12(1):22. doi: 10.3390/biomedicines12010022.
9
Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinoma.三氧化二砷与奥希替尼联合治疗复发和转移性头颈部鳞状细胞癌
Am J Cancer Res. 2022 Nov 15;12(11):5049-5061. eCollection 2022.
10
Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.BRCA1/2 突变携带者的正常乳腺组织中免疫细胞增多。
Breast Cancer Res Treat. 2023 Jan;197(2):277-285. doi: 10.1007/s10549-022-06786-y. Epub 2022 Nov 16.
PDX 模型反映了小儿急性淋巴细胞白血病的蛋白质组景观,但在某些途径上存在差异。
J Exp Clin Cancer Res. 2021 Mar 15;40(1):96. doi: 10.1186/s13046-021-01835-8.
4
Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors.Brca1 相关乳腺肿瘤发生的时间分辨单细胞分析显示管腔祖细胞的异常分化。
Nat Commun. 2021 Mar 9;12(1):1502. doi: 10.1038/s41467-021-21783-3.
5
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.乳腺癌风险基因 - 超过 113000 名女性的关联分析。
N Engl J Med. 2021 Feb 4;384(5):428-439. doi: 10.1056/NEJMoa1913948. Epub 2021 Jan 20.
6
A Population-Based Study of Genes Previously Implicated in Breast Cancer.基于人群的先前与乳腺癌相关的基因研究。
N Engl J Med. 2021 Feb 4;384(5):440-451. doi: 10.1056/NEJMoa2005936. Epub 2021 Jan 20.
7
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.NOTCH1 激活补偿 BRCA1 缺陷并促进三阴性乳腺癌的形成。
Nat Commun. 2020 Jun 26;11(1):3256. doi: 10.1038/s41467-020-16936-9.
8
A Model of Differential Mammary Growth Initiation by Stat3 and Asymmetric Integrin-α6 Inheritance.Stat3 和不对称整合素-α6 遗传差异启动乳腺生长的模型。
Cell Rep. 2020 Mar 17;30(11):3605-3615.e5. doi: 10.1016/j.celrep.2020.02.079.
9
Defining and Modulating 'BRCAness'.定义和调节“BRCA 样特征”。
Trends Cell Biol. 2019 Sep;29(9):740-751. doi: 10.1016/j.tcb.2019.06.005. Epub 2019 Jul 27.
10
Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.DNA 损伤修复不足促进乳腺转分化,导致 BRCA1 型乳腺癌。
Cell. 2019 Jun 27;178(1):135-151.e19. doi: 10.1016/j.cell.2019.06.002.